Literature DB >> 3743615

Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.

M A van Baak, F T Verstappen, B Oosterhuis.   

Abstract

The effects of oxprenolol, a non-selective beta-blocker with moderate intrinsic sympathomimetic activity (ISA), given by the Oros delivery system, on resting and exercise heart rate and blood pressure have been compared over a 24-h period with those of atenolol, a beta 1-selective blocker without ISA. The effects on maximal and submaximal exercise tolerance and perceived exertion were studied in relation to the level of beta-blockade. 9 healthy subjects were treated with placebo, atenolol, 100 mg/day and oxprenolol Oros, 16/260 mg/day in random order, each for 5 days. Progressive maximal exercise tests and submaximal endurance tests at 80% of maximum aerobic exercise capacity were performed 2, 5 and 24 h after intake of the drugs. The reduction of blood pressure 2 and 5 h after drug intake was less pronounced after oxprenolol Oros than after atenolol, but by 24 h after the last dose the effects were similar. The peak level of beta-blockade (i.e. reduction in maximal exercise heart rate) was similar after oxprenolol Oros and atenolol. The minimal level of beta-blockade 24 h after the last dose was greater after oxprenolol Oros than after atenolol. Maximal exercise capacity and submaximal exercise tolerance were impaired after both beta-blockers. The subjective feeling of exertion did not differ between placebo, atenolol and oxprenolol Oros when related to the relative work load, except after the first minute of exercise, when the rating of perceived exertion was higher after atenolol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743615     DOI: 10.1007/bf00607951

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

Review 1.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.

Authors:  W Frishman
Journal:  Am Heart J       Date:  1979-05       Impact factor: 4.749

Review 2.  beta-Adrenoceptor blockade and exercise: effects on endurance and physical training.

Authors:  A Juhlin-Dannfelt
Journal:  Acta Med Scand Suppl       Date:  1983

3.  Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).

Authors:  J Erikssen; E Thaulow; R Mundal; P Opstad; S Nitter-Hauge
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Effect of beta-adrenoceptor blockade on exercise performance and metabolism.

Authors:  P Lundborg; H Aström; C Bengtsson; E Fellenius; H von Schenck; L Svensson; U Smith
Journal:  Clin Sci (Lond)       Date:  1981-09       Impact factor: 6.124

5.  Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.

Authors:  H Folgering; M van Bussel
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

6.  Effects of beta-adrenergic receptor blockade on metabolic rate and mixed venous blood temperature during dynamic exercise.

Authors:  T Brundin
Journal:  Scand J Clin Lab Invest       Date:  1978-05       Impact factor: 1.713

7.  Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.

Authors:  J D Fitzgerald; R Ruffin; K G Smedstad; R Roberts; J McAinsh
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

8.  Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration.

Authors:  F Theeuwes; D R Swanson; G Guittard; A Ayer; S Khanna
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

9.  Gas chromatographic determination of metoprolol in human plasma.

Authors:  A Sioufi; F Leroux; N Sandrenan
Journal:  J Chromatogr       Date:  1983-01-14

10.  Effect of beta-adrenoceptor blockade on thermoregulation during prolonged exercise.

Authors:  N F Gordon; P E Krüger; J P Van Rensburg; A Van der Linde; A J Kielblock; J F Cilliers
Journal:  J Appl Physiol (1985)       Date:  1985-03
View more
  5 in total

Review 1.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

2.  Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.

Authors:  M A van Baak; F M Koene; F T Verstappen
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

3.  Exercise tolerance with nebivolol and atenolol.

Authors:  L M Van Bortel; M A van Baak
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

4.  Exercise performance during captopril and atenolol treatment in hypertensive patients.

Authors:  M A Van Baak; F M Koene; F T Verstappen; E S Tan
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

5.  Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.

Authors:  F T Verstappen; M A van Baak
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.